Monographie - Colistin mesilate sodium

Ultimele actualizari :
08/05/2024

Colistin mesilate sodium

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfacolin	Argentina
Alficetin	Argentina
Colent	Chilli
Colimicina	Italia, Spania
Colimycin	Danemarca, Norvegia, Turcia
Colimycine	Franta, Luxemburg, Maroc, Olanda, Tunisia
Colismet	Peru
Colisti Ject	Egipt
Colistimetal sodic	Romania
Colistimetato de sodio	Chilli, Peru, Spania
Colistimethate	Canada, Marea Britanie, SUA
Colistin	Austria, Grecia, Noua Zeelandă, Polonia
Colistina	Argentina, Portugalia
Colistineb	Belgia
Colistyn	Argentina
Colixin	Portugalia
Colomycin	Canada, Irlanda, Malaezia, Marea Britanie, SUA
Coly-Mycin	Australia, SUA
Cotrelan	Argentina
Dicupal	Chilli
Elistin	Peru
Kolisod	Turcia
Nolisin	Argentina
Promixin	Irlanda, Marea Britanie, Norvegia
Toliscrin	Argentina

Bibliografie : Colistin mesilate sodium

	Tip	Publicare
1201	Ziar	Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG. Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Am J Hosp Pharm 1981 ; 38: 1919-1922.
2285	Ziar	Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL. Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.
2550	Ziar	Roberts GW, Rossi S.O.P. Compatibility of nebulizer solutions Aust J Hosp Pharm 1993 ; 23: 35-37.
2783	Ziar	Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P. Stability of colistimethate sodium in a disposable elastomeric infusion device. Int J Pharm 2015 ; 486; 1-2: 367-369.
3254	Ziar	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3360	Ziar	Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J. Stability of Colistimethate Sodium in Aqueous Solution. Antimicrob Agents Chemother 2012 ; 56:6432-6433.
3674	Laborator	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3827	Poster	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	Poster	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	Poster	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
3997	Ziar	Katip W. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055	Ziar	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145	Ziar	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4178	Ziar	Post T.E, Kamerling I, van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E. Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration. EJHP 2017 ; 25, e2
4319	Ziar	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4434	Ziar	Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clin Ther 2019 ; 41, 10: 2162-2170.
4438	Ziar	Stawny M, Gostyńska A, Nadolna M, Jelińska A. Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition Pharmaceutics 2020 ; 12: 292
4528	Ziar	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4801	Ziar	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales